Encountering and Anchoring Opportunities in an Era of Uncertainty: Exploring the Trends and Core Risks of Mergers and Acquisitions of Chinese Biotech Companies
1. Introduction
Since the end of 2023, the mergers and acquisitions (M&A) trend in China’s life sciences industry has garnered substantial interest.